MoneyWorks4Me

Biogen Pharmachem - Quaterly Results

05 Feb 2025 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended December 2024, as compared to corresponding quarter of last year.The Net Loss for the quarter ended December 2024 is Rs. -3.14 millions as compared to Net Profit of Rs. 0.62 millions of corresponding quarter ended December 2023Operating profit Margin for the quarter ended December 2024 slipped to -3.14% as compared to 0.62% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 -0.91 7.53 -112.08 23.82 9.13 160.90
Other Income 2.28 0.92 147.83 -4.22 8.49 -149.71 0.00 0.00 0.00
PBIDT -3.14 0.62 -606.45 -14.69 11.89 -223.55 19.31 4.56 323.46
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -3.14 0.62 -606.45 -14.69 11.89 -223.55 19.31 4.56 323.46
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -3.14 0.62 -606.45 -14.69 11.89 -223.55 19.31 4.56 323.46
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -3.14 0.62 -606.45 -14.69 11.89 -223.55 19.31 4.56 323.46
Equity 652.60 652.60 0.00 652.60 652.60 0.00 652.60 652.60 0.00
PBIDTM(%) 0.00 0.00 0.00 1614.29 157.90 922.34 81.07 49.95 62.31
Peers
Company Name CMP
Redington 392.20
Amrapali Industries 37.05
Adani Enterprises 3100.00
Rashi Peripheral 805.00
PDS 348.90
View more..